Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pulmatrix, Inc. Director's Dealing 2015

Jun 18, 2015

35037_dirs_2015-06-17_88d71b32-3fcb-46fd-bda6-d0b13020481b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmatrix, Inc. (PULM)
CIK: 0001574235
Period of Report: 2015-06-15

Reporting Person: Clarke Robert W. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-06-15 Common Stock A 18667 Acquired 18667 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-06-15 Stock Option (Right to Buy) $2.20 A 7190 Acquired 2020-02-10 Common Stock (7190) Direct
2015-06-15 Stock Option (Right to Buy) $2.20 A 2413 Acquired 2020-05-24 Common Stock (2413) Direct
2015-06-15 Stock Option (Right to Buy) $2.20 A 11855 Acquired 2021-06-15 Common Stock (11855) Direct
2015-06-15 Stock Option (Right to Buy) $2.03 A 23710 Acquired 2022-06-08 Common Stock (23710) Direct
2015-06-15 Stock Option (Right to Buy) $2.03 A 171009 Acquired 2022-09-18 Common Stock (171009) Direct
2015-06-15 Stock Option (Right to Buy) $1.88 A 65626 Acquired 2023-10-11 Common Stock (65625) Direct
2015-06-16 Stock Option (Right to Buy) $11.80 A 407907 Acquired 2025-06-16 Common Stock (407907) Direct

Footnotes

F1: Reflects a 1-for-2.5 reverse stock split effected on June 15, 2015.

F2: On June 15, 2015, the Reporting Person received these shares of the Issuer's Common Stock in exchange for securities of a private company formerly known as Pulmatrix, Inc. (the "Former Entity") in connection with the merger of the Former Entity into the Issuer (the "Merger").

F3: These securities were received in the Merger in exchange for a stock option to acquire 121,293 shares for $0.13 per share of common stock of the Former Entity.

F4: These options are fully vested and exercisable.

F5: These securities were received in the Merger in exchange for a stock option to acquire 40,699 shares for $0.13 per share of common stock of the Former Entity.

F6: These securities were received in the Merger in exchange for a stock option to acquire 200,000 shares for $0.13 per share of common stock of the Former Entity.

F7: These options vested/vest over a four-year period, with 25% vesting on the first anniversary of the initial date of grant by the Former Entity and 2.083% vesting each month thereafter for thirty-six months.

F8: These securities were received in the Merger in exchange for a stock option to acquire 400,000 shares for $0.12 per share of common stock of the Former Entity.

F9: These securities were received in the Merger in exchange for a stock option to acquire 2,885,000 shares for $0.12 per share of common stock of the Former Entity.

F10: These securities were received in the Merger in exchange for a stock option to acquire 1,071,120 shares for $0.11 per share of common stock of the Former Entity.

F11: These options vested/vest over a four-year period, with 50% vesting on the first anniversary of the initial date of grant by the Former Entity and 4.167% vesting each month thereafter for twelve months.

F12: These options vest as to 25% on June 15, 2016 and 2.08% monthly thereafter. In the event of a change of control of the Issuer, the option shall become vested in full.